Everest Medicines Market Cap

Everest Medicines has a market cap or net worth of 12.58 billion as of March 9, 2026. Its market cap has increased by 3.94% in one year.

Market Cap

12.58B

Enterprise Value

11.64B

Revenue

932.82M

Ranking

n/a

PE Ratio

n/a

Stock Price

37.22

Market Cap Chart

Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 12.58B, a decrease of -39.06%. That is a compound annual growth rate of -8.74%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	12.58B	-3.73%
Dec 31, 2025	13.06B	-16.21%
Dec 31, 2024	15.59B	132.87%
Dec 29, 2023	6.70B	24.60%
Dec 30, 2022	5.37B	-47.96%
Dec 31, 2021	10.33B	-47.98%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nanjing Leads Biolabs	12.12B
Guangzhou Innogen Pharmaceutical Group	11.05B
Ascletis Pharma	15.28B
Keymed Biosciences	15.44B
HBM Holdings	10.08B
Shanghai Haohai Biological Technology	9.96B
CStone Pharmaceuticals	9.54B
Ascentage Pharma Group International	16.66B

Market Cap Rankings